Aterian (ATER) Projected to Post Earnings on Thursday

Aterian (NASDAQ:ATERGet Free Report) will likely be releasing its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect Aterian to post earnings of ($0.69) per share and revenue of $15.82 million for the quarter. Interested persons may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 5:00 PM ET.

Aterian Price Performance

NASDAQ ATER opened at $1.26 on Thursday. The firm has a market cap of $13.63 million, a PE ratio of -0.52 and a beta of 0.66. The company has a 50 day moving average price of $0.67 and a 200 day moving average price of $0.74. Aterian has a 52 week low of $0.52 and a 52 week high of $2.19.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aterian in a research report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Read Our Latest Analysis on Aterian

Institutional Trading of Aterian

Large investors have recently bought and sold shares of the stock. XTX Topco Ltd purchased a new stake in shares of Aterian in the 2nd quarter valued at $55,000. Goldman Sachs Group Inc. boosted its holdings in shares of Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares during the last quarter. Susquehanna International Group LLP boosted its holdings in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares during the last quarter. Finally, Citadel Advisors LLC boosted its holdings in shares of Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after acquiring an additional 22,865 shares during the last quarter. Hedge funds and other institutional investors own 7.02% of the company’s stock.

About Aterian

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Recommended Stories

Earnings History for Aterian (NASDAQ:ATER)

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.